The pharmaceutical industry is undergoing a fundamental shift in how supply chains are managed. As products become more complex – biologics, cell and gene therapies, temperature-sensitive vaccines – the margin for error in logistics shrinks to near zero. Traditional monitoring approaches, built around passive data loggers and post-delivery analysis, are no longer sufficient. Today's pharma…